Matches in Wikidata for { <http://www.wikidata.org/entity/Q95659385> ?p ?o ?g. }
- Q95659385 description "2020 nî lūn-bûn" @default.
- Q95659385 description "2020年の論文" @default.
- Q95659385 description "2020年学术文章" @default.
- Q95659385 description "2020年学术文章" @default.
- Q95659385 description "2020年学术文章" @default.
- Q95659385 description "2020年学术文章" @default.
- Q95659385 description "2020年学术文章" @default.
- Q95659385 description "2020年学术文章" @default.
- Q95659385 description "2020年學術文章" @default.
- Q95659385 description "2020年學術文章" @default.
- Q95659385 description "2020年學術文章" @default.
- Q95659385 description "2020年學術文章" @default.
- Q95659385 description "2020年學術文章" @default.
- Q95659385 description "2020년 논문" @default.
- Q95659385 description "article científic" @default.
- Q95659385 description "article scientific" @default.
- Q95659385 description "article scientifique" @default.
- Q95659385 description "articol științific" @default.
- Q95659385 description "articolo scientifico" @default.
- Q95659385 description "artigo científico" @default.
- Q95659385 description "artigo científico" @default.
- Q95659385 description "artigo científico" @default.
- Q95659385 description "artikel ilmiah" @default.
- Q95659385 description "artikull shkencor" @default.
- Q95659385 description "artikulong pang-agham" @default.
- Q95659385 description "artykuł naukowy" @default.
- Q95659385 description "artículo científico publicado en 2020" @default.
- Q95659385 description "artículu científicu" @default.
- Q95659385 description "bilimsel makale" @default.
- Q95659385 description "bài báo khoa học" @default.
- Q95659385 description "naučni članak" @default.
- Q95659385 description "scienca artikolo" @default.
- Q95659385 description "scientific article published on 22 May 2020" @default.
- Q95659385 description "scientific article published on 22 May 2020" @default.
- Q95659385 description "scientific article published on 22 May 2020" @default.
- Q95659385 description "teaduslik artikkel" @default.
- Q95659385 description "tieteellinen artikkeli" @default.
- Q95659385 description "tudományos cikk" @default.
- Q95659385 description "vedecký článok" @default.
- Q95659385 description "vetenskaplig artikel" @default.
- Q95659385 description "videnskabelig artikel udgivet 22. maj 2020" @default.
- Q95659385 description "vitenskapelig artikkel" @default.
- Q95659385 description "vitskapeleg artikkel" @default.
- Q95659385 description "vědecký článek" @default.
- Q95659385 description "wetenschappelijk artikel" @default.
- Q95659385 description "wissenschaftlicher Artikel" @default.
- Q95659385 description "επιστημονικό άρθρο" @default.
- Q95659385 description "мақолаи илмӣ" @default.
- Q95659385 description "наукова стаття, опублікована в травні 2020" @default.
- Q95659385 description "научна статия" @default.
- Q95659385 description "научная статья" @default.
- Q95659385 description "научни чланак" @default.
- Q95659385 description "научни чланак" @default.
- Q95659385 description "מאמר מדעי" @default.
- Q95659385 description "مقالة علمية نشرت في 22 مايو 2020" @default.
- Q95659385 description "২২ মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q95659385 description "บทความทางวิทยาศาสตร์" @default.
- Q95659385 description "სამეცნიერო სტატია" @default.
- Q95659385 name "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.
- Q95659385 name "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.
- Q95659385 type Item @default.
- Q95659385 label "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.
- Q95659385 label "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.
- Q95659385 prefLabel "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.
- Q95659385 prefLabel "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.
- Q95659385 P1433 Q95659385-3CE9E20C-FFCF-4370-9E24-0E44FBE85640 @default.
- Q95659385 P1476 Q95659385-E4EEA4CE-499B-43E5-BEEA-BE8D64C64481 @default.
- Q95659385 P2093 Q95659385-06CE9CCD-04CE-496A-AAB9-C8E950E8DF4F @default.
- Q95659385 P2093 Q95659385-2650D09A-E45A-4A51-95D1-F5DB7C85AD17 @default.
- Q95659385 P2093 Q95659385-29C85A51-34AC-4D56-B5D7-0C3A19E17B20 @default.
- Q95659385 P2093 Q95659385-310D30B1-B5BC-47E7-B0E9-7992D528B5E3 @default.
- Q95659385 P2093 Q95659385-72376178-1033-4FE7-B7F8-48F409D1CEBF @default.
- Q95659385 P2093 Q95659385-7895A0B9-DCAA-441C-959A-7CCC73156CEB @default.
- Q95659385 P2093 Q95659385-79B858C4-1FD2-4C24-A547-0D73874CC2C4 @default.
- Q95659385 P2093 Q95659385-7A6DAAF9-C7A3-45F2-81B7-2842E41DE25A @default.
- Q95659385 P2093 Q95659385-940F82AD-09CA-4EA6-855A-1CE3CD02725E @default.
- Q95659385 P2093 Q95659385-9D9C28AC-3426-4F8A-95D6-01D75BB7B0F9 @default.
- Q95659385 P2093 Q95659385-BB9C3B4F-2C6F-438E-A15B-5A07E2FC5626 @default.
- Q95659385 P2093 Q95659385-CB643B4D-6007-4CB1-9419-778701C9D86C @default.
- Q95659385 P2093 Q95659385-D722AED8-0EEE-4087-A7C7-558609B756FB @default.
- Q95659385 P2093 Q95659385-D72AA49D-955B-48B0-AC8F-A5D6C078E7E5 @default.
- Q95659385 P2093 Q95659385-D8582656-2CF6-4BDA-8196-44204452B0DB @default.
- Q95659385 P2093 Q95659385-DAD64544-98FB-4F73-A155-29CD33CF2C23 @default.
- Q95659385 P2093 Q95659385-E748E990-F8FF-4C5E-9CC1-50F75901B753 @default.
- Q95659385 P2860 Q95659385-8C5EA9CF-2EB3-41C0-A2D7-B33302945155 @default.
- Q95659385 P31 Q95659385-099D1CE2-114C-48CA-A523-BAC339ED4C19 @default.
- Q95659385 P356 Q95659385-2A903C3C-605A-4A01-83A4-9130818B950A @default.
- Q95659385 P50 Q95659385-D0E3B399-B090-4BB9-BF61-A3CC91304D63 @default.
- Q95659385 P50 Q95659385-E53ED289-6E37-4D75-B8B7-F8A05616A9C1 @default.
- Q95659385 P50 Q95659385-E89A77D6-D028-48D8-ADE8-8EDC945A7778 @default.
- Q95659385 P577 Q95659385-E04C87AF-B959-48F5-8E9D-7CF1FF3AAE42 @default.
- Q95659385 P698 Q95659385-9FD02E4B-1C4F-4B9A-9027-4BA60232DE3F @default.
- Q95659385 P921 Q95659385-1E73D7DA-0D5F-443E-A8B0-FC85320D13CD @default.
- Q95659385 P921 Q95659385-2544DAB0-5A2C-4CB0-A20B-242FEF140201 @default.
- Q95659385 P921 Q95659385-3E5983A2-2C10-47EA-94A3-CDA51800468C @default.
- Q95659385 P921 Q95659385-A8B90E91-FBDA-4BFB-A754-5A10303E6A07 @default.
- Q95659385 P356 1078-0432.CCR-19-4121 @default.
- Q95659385 P698 32444417 @default.
- Q95659385 P1433 Q332253 @default.
- Q95659385 P1476 "EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression" @default.